Clinical Overview
Tranylcypromine is a monoamine oxidase inhibitor (MAOI) indicated for treatment-resistant depression. It is one of the most potent MAOIs and may have some stimulant-like properties due to its structural similarity to amphetamine. Like all MAOIs, it requires strict dietary restrictions and careful monitoring for drug interactions, but can be highly effective for atypical depression and treatment-resistant cases.
Primary Clinical Applications
Tranylcypromine is indicated for major depressive disorder in patients who have not responded to other antidepressant therapies. It may be particularly effective for atypical depression characterized by mood reactivity, hypersomnia, hyperphagia, rejection sensitivity, and leaden paralysis. It is typically reserved for treatment-resistant cases due to its side effect profile and dietary restrictions.
Mechanism and Clinical Benefits
Tranylcypromine irreversibly inhibits both MAO-A and MAO-B enzymes, increasing levels of norepinephrine, serotonin, and dopamine. Its structural similarity to amphetamine may contribute to mild stimulant effects, potentially providing energy and motivation benefits in addition to antidepressant effects. This broad mechanism may explain its efficacy in treatment-resistant depression.
Safety and Monitoring Requirements
Treatment requires strict adherence to tyramine-restricted diet and careful monitoring for hypertensive crises. Patients must avoid numerous medications and foods high in tyramine. The irreversible nature of MAO inhibition means effects persist for weeks after discontinuation, requiring extended washout periods when switching to other antidepressants.
Prescribing Information
Dosing & Administration
Depression – Adults:
- Initial: 10 mg twice daily
- Titration: May increase by 10 mg daily every 1-3 weeks
- Range: 20-60 mg daily in divided doses
- Maximum: 60 mg daily
Elderly:
- Initial: 5 mg twice daily
- Titrate very slowly with careful monitoring
- Lower maximum doses typically required
Administration:
- Divide daily dose into 2-3 administrations
- Take with food to reduce GI upset
- Avoid evening doses due to potential stimulant effects
- Consistent timing each day
Indications
- Treatment of major depressive disorder in patients who have not responded to other antidepressant therapy
- Typically reserved for treatment-resistant depression
Contraindications
- Hypersensitivity to tranylcypromine
- Concomitant use with other MAOIs, SSRIs, SNRIs, tricyclics
- Use with sympathomimetics, meperidine, dextromethorphan
- Pheochromocytoma
- Cardiovascular disease, cerebrovascular disease
- Severe renal or hepatic impairment
- History of headache
Warnings & Precautions
- Boxed Warning: Increased risk of suicidal thoughts and behavior in patients under 25 years
- Hypertensive crisis: Risk with tyramine-containing foods and certain drugs
- Dietary restrictions: Strict tyramine-free diet required
- Drug interactions: Extensive list of contraindicated medications
- Withdrawal: Taper gradually to avoid discontinuation syndrome
- Stimulant effects: May cause insomnia, agitation, hypertension
Drug Interactions
- Antidepressants: Wait 14 days between MAOI and other antidepressants (5 weeks from fluoxetine)
- Sympathomimetics: Risk of hypertensive crisis
- Meperidine: Contraindicated – risk of serotonin syndrome
- Tyramine-rich foods: Hypertensive crisis risk
- Anesthetics: Discontinue 10 days before elective surgery
Adverse Reactions
Common:
- Orthostatic hypotension, dizziness, headache, insomnia
- Dry mouth, constipation, nausea, agitation
Stimulant-like effects:
- Insomnia, restlessness, hypertension, tremor
Serious:
- Hypertensive crisis, hepatotoxicity, serotonin syndrome
Special Populations
- Elderly: Increased risk of orthostatic hypotension and drug interactions
- Hepatic/Renal Impairment: Contraindicated in severe impairment
- Pregnancy: Category C – use only if clearly needed
- Dietary Education: Essential patient counseling on tyramine restrictions
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
